Immunological mechanisms of mRNA vaccines for infectious diseases

💲 Paywalled: This content may require a subscription. Manage paywalled content settings on Scour.

Nucleoside-modified mRNA–lipid-nanoparticle (mRNA–LNP) vaccines confer a high level of protection against severe COVID-19 and, since their first authorization for human use in 2020, have saved millions of lives. The efficacy of this vaccine platform relies on the induction of powerful and coordinate…

View Post on Scour ↗

More from Nature on Scour.